Pro Medicus Limited

ASX (AUD): Pro Medicus Limited (PME)

Last Price

116.29

Today's Change

+3.19 (2.82%)

Day's Change

113.60 - 116.29

Trading Volume

334,692

Overview

Market Cap

12 Billion

Shares Outstanding

104 Million

Avg Volume

332,333

Avg Price (50 Days)

103.93

Avg Price (200 Days)

90.31

PE Ratio

173.57

EPS

0.67

Earnings Announcement

15-Feb-2024

Previous Close

113.10

Open

115.98

Day's Range

113.6 - 116.29

Year Range

58.6 - 116.29

Trading Volume

334,692

Price Change Highlight

1 Day Change

2.82%

5 Day Change

3.74%

1 Month Change

7.50%

3 Month Change

8.76%

6 Month Change

36.47%

Ytd Change

20.76%

1 Year Change

93.91%

3 Year Change

179.75%

5 Year Change

526.23%

10 Year Change

13826.95%

Max Change

10012.17%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Health Information Services

Description:

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment